July 18 (Reuters) – AstraZeneca Plc said its
experimental lung cancer drug Tagrisso met its main goal in a
late-stage study.
The post UPDATE 1-AstraZeneca’s lung cancer drug meets main goal in late-stage trial appeared first on NASDAQ.
UPDATE 1-AstraZeneca’s lung cancer drug meets main goal in late-stage trial
